Overactive%20bladder Patient Education

Patient Education

The clinician should discuss the normal and abnormal bladder function, including voiding frequency and toileting behavior
With the initiation of antimuscarinic medications, some adverse effects such as dry mouth and constipation may indicate that the treatment is starting to have an effect and this should be thoroughly discussed and explained to the patient
Patients should be informed that overactive bladder (OAB) is a symptom complex with variable and chronic course that needs to be managed over time and primarily affects the quality of life
Helps the patient understand that voiding is a behavior that can be managed and the success in the treatment requires a willing participant who is informed and engaged in the treatment process

Lifestyle Modification

Fluid intake
- Lessen fluid intake in the evening or before bedtime
- Eliminate alcohol and caffeine, particularly in the evening

Smoking cessation
- Nicotine can irritate the bladder and cause bladder contraction and urgency
- Coughing due to smoking will cause urinary leakage

Stress
- To reduce stress, techniques such as meditation, yoga, breathing techniques and music relaxation may relieve symptoms

Diet
- Foods such as tomato-based, highly spiced, fruits and fruit juices, frizzy drinks and foods containing chocolate, tea and coffee should be eliminated in the diet, as this can irritate and trigger overactive bladder (OAB)
- Increase intake of dietary fiber as constipation can put pressure in an OAB

Exercise
- Being obese and overweight might increase symptoms of OAB, as this increases the pressure on the bladder or other neurological conditions
- Pelvic muscle floor should be considered in patients with lower urinary tract dysfunction due to multiple sclerosis or stroke and other neurological conditions where there is a potential voluntary contraction of the pelvic floor

Dry Mouth
- This is due to the adverse effect of the anticholinergic drugs
- The patient should be advised to sip water

Products used to help living with overactive bladder (OAB)

Portable Urinals
- Find the one that will fit inside the handbag or in the glove box of the car

Protective Underwear or Pads
- Those patients with leakage issue, using or wearing a pad can help with any leakage of urine, from mild, medium to heavy

Waterproof Bedding
- This is advised for those who experience nocturnal enuresis

Product Highlight - Lanzotred

13 Sep 2023

Enzalutamide 40 mg softcap

Optimizing metastatic hormone-sensitive prostate cancer treatment in advanced prostate cancer

Assoc Prof. Darren Poon, Assoc Prof. Edmund Chiong, 14 Jan 2021

Metastatic hormone-sensitive prostate cancer (mHSPC) refers to the condition whereby patients have metastatic prostate cancer and no prior hormonal therapy or androgen deprivation therapy (ADT). Typically, patients with mHSPC have been treated with ADT alone, following which, the overwhelming majority develop castration resistance over time and head towards eventual mortality. In recent years, the publication of various landmark trials has prompted dramatic changes in the mHSPC treatment landscape, and had favourably impacted overall survival (OS) in these patients. At a recent webinar, A/Prof Darren Poon, Honorary Consultant in Clinical Oncology, Hong Kong Sanatorium & Hospital, and Honorary Clinical Associate Professor, Department of Clinical Oncology, The Chinese University of Hong Kong, reviewed treatment options in mHSPC, while A/Prof Edmund Chiong, Head and Senior Consultant, Department of Urology, National University Hospital, Singapore, presented a case which was discussed by an esteemed panel of experts. This webinar was jointly organized by the Singapore Society of Oncology and the Singapore Urological Association, and supported by Astellas.